Cargando…

Preventing Medication Errors and Adverse Drug Events

Detalles Bibliográficos
Autor principal:	Curtiss, Frederic R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2003
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437177/ https://www.ncbi.nlm.nih.gov/pubmed/14613373 http://dx.doi.org/10.18553/jmcp.2003.9.1.92

Ejemplares similares

Protecting Patients from Adverse Drug Events: Propoxyphene, PIMs, and Drugs to Avoid in Older Adults
por: Curtiss, Frederic R., et al.
Publicado: (2011)

Preventable Drug-related Morbidity (PDRM)
por: Curtiss, Frederic R.
Publicado: (2003)

Overview of medical errors and adverse events
por: Garrouste-Orgeas, Maité, et al.
Publicado: (2012)

Contractual Arrangements Between HMOs and Medical Groups to Manage Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

False-Positive Versus True-Positive Drug-Drug Interactions With Warfarin
por: Curtiss, Frederic R.
Publicado: (2006)

Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: the Japan Adverse Drug Events (JADE) Study
por: Ayani, Nobutaka, et al.
Publicado: (2022)

Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review
por: Mekonnen, Alemayehu B., et al.
Publicado: (2017)

Prior Authorization to Manage Drug Utilization and Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Burden of Prescription Drug Costs in the United States
por: Curtiss, Frederic R.
Publicado: (2003)

COX-2 Inhibitors: Little or No GI Protection, Increased Risk of Cardiovascular Events, High Cost, and Other Class-less Effects
por: Curtiss, Frederic R.
Publicado: (2005)

HEDIS, Beta-Blockers, and What More Can Be Done to Improve Secondary Prevention in ACS
por: Curtiss, Frederic R.
Publicado: (2008)

HIPAA Effects on Health Research and PBM Functions in Drug Utilization Review
por: Curtiss, Frederic R.
Publicado: (2003)

Antihypertensive Drug Effects on Renal Function and Myocardial Infarction and Implications of the ALLHAT Study Results
por: Curtiss, Frederic R.
Publicado: (2003)

Pharmacy Benefit Spending Poised to Increase for Antithrombotic Drug Therapy--Prasugrel Versus Clopidogrel
por: Curtiss, Frederic R.
Publicado: (2009)

It Depends on What Mean Means: Averaging Versus Event Patterning in Analyses of Administrative Claims Data
por: Fairman, Kathleen A., et al.
Publicado: (2010)

Omalizumab and Other New Drug Therapies Occupy a Small Space in Asthma Disease Management
por: Curtiss, Frederic R.
Publicado: (2009)

Contradictory Actions on Off-Label Use of Prescription Drugs? The FDA and CMS Versus the U.S. Justice Department
por: Curtiss, Frederic R.
Publicado: (2009)

Hypertension, Prescription Drug Copayments, and Drug Therapy Adherence
por: Curtiss, Frederic R.
Publicado: (2003)

Diabetes Drug Therapy -- First Do No Harm
por: Curtiss, Frederic R., et al.
Publicado: (2008)

Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review
por: Alghamdi, Anwar A., et al.
Publicado: (2019)

Epidemiology of Adverse Events and Medical Errors in the Care of Cardiology Patients
por: Ohta, Yoshinori, et al.
Publicado: (2019)

Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia
por: Dedefo, Mohammed Gebre, et al.
Publicado: (2016)

The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study
por: Ayani, Nobutaka, et al.
Publicado: (2016)

Reporting adverse drug events to the Therapeutic Goods Administration
por: Martin, Jennifer H, et al.
Publicado: (2021)

Effects of Physician Report Cards, Knowledge of Drug Prices, and Financial Incentives in Prescription Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Tough Questions About the Value of Statin Therapy for Primary Prevention: Did JUPITER Miss the Moon?
por: Curtiss, Frederic R., et al.
Publicado: (2010)

3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes
por: Curtiss, Frederic R.
Publicado: (2004)

Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010
por: Fairman, Kathleen A., et al.
Publicado: (2010)

The Elephant in the Pharmacy: Patient Choice Is the Big Challenge That No One Talks About in Affordability of Prescription Drugs
por: Fairman, Kathleen A., et al.
Publicado: (2007)

The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective database study
por: Sutherland, Adam, et al.
Publicado: (2022)

Does Medicalization of Life Imperil Health? Expanding Indications for Diagnosis and Treatment of Chronic “Disease”
por: Fairman, Kathleen A., et al.
Publicado: (2011)

VBID, the PPACA, and FREEE Medications: Did Politics Trump the Evidence About Cost Sharing?
por: Fairman, Kathleen A., et al.
Publicado: (2012)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Does Persistence With Drugs for Alzheimer's Disease Matter?
por: Curtiss, Frederic R.
Publicado: (2005)

Unraveling the Effects of Tier-Copayment Drug Benefit Designs
por: Curtiss, Frederic R.
Publicado: (2003)

Involvement of Pharmacists in the Emergency Department to Correct Errors in the Medication History and the Impact on Adverse Drug Event Detection
por: Goulas, Clara, et al.
Publicado: (2023)

TMAC Savings of 90% for Heartburn Drugs in the United States
por: Curtiss, Frederic R.
Publicado: (2006)

Medication Therapy Management Programs - Will Patient Need be Satisfied
por: Curtiss, Frederic R.
Publicado: (2005)

Methods to Attain Optimal Outcomes With Lipid-Lowering Drug Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
por: Curtiss, Frederic R.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_vlgugqc3u1adrej6bdeaklhtbg